RE:RE:RE:in vivo clinical results This will be an interesting presentation, not so much for thinking we will get any hard trial data (I would expect nothing more than a "...everything is on track, we are pleased with clinics, so far data collection all going as planned and no surprises, will have answers shortly and will commence part 2..." ), but it seems from the wording that LSA has helped them string together the key aspects and advantages of the approach in a punchier and more convincing way. They lay out the reasons why this "could" be a seriously disrupting science that they own 100% of. To me it seems more convincing and logical - maybe they are getting more confident about it as experienced outsiders see all the facts lining up and tell them to push the arguments forward. Let's see if the management portion of the call is also lines of the themes they've incorporated in the PR.
if so, maybe we will finally Keep that U$4 handle going forward. FTV - maybe your $5 level will be in sight for the summer.
muslix1 wrote:
the market dont like the news ...
people are nervous good sing